Kiromic Biopharma, Inc. (KRBPQ) Cash flow
Market cap
$153.33
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 13 | 4 | 1 | 0 | 1 |
| Cash from operations | -6 | -20 | -23,745,900 | -21,225,300 | -19 |
| Capital expenditures | -1 | -2 | -5 | -0 | -0 |
| Cash from investing | -1 | -2 | -5 | -0 | -0 |
| Cash from financing | 16 | 37 | 4 | 24 | 18 |
| Free cash flow |